Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7423-7430

  Pène, Jérôme ^a   Chevalier, Sylvie ^b   Preisser, Laurence ^b   Véneréau, Emilie ^b   Guilleux, Marie Hélène ^b   Ghannam, Soufiane ^a   Molès, Jean Pierre ^c   Danger, Yannic ^b   Ravon, Elisa ^b   Lesaux, Sabine ^b   Yssel, Hans ^a   Gascan, Hugues ^b  

^a INSERM   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 26; LYMPHOTOXIN BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TUMOR NECROSIS FACTOR ALPHA; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CYTOKINE; ORPHAN NUCLEAR RECEPTOR ROR GAMMA; ORPHAN NUCLEAR RECEPTOR ROR-GAMMA; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR;

ALLERGIC ASTHMA; ARTICLE; CELL CULTURE; CELL ISOLATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH17 CELL; TH2 CELL; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION PROFILING; HELPER CELL; IMMUNOLOGY; INFLAMMATION; KERATINOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; TH1 CELL;

AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INTERLEUKIN-17; KERATINOCYTES; LYMPHOCYTE ACTIVATION; RECEPTORS, CCR6; RECEPTORS, CHEMOKINE; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 47249125726     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7423     Document Type: Article

References (41)

1. O'Garra, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10: 801-805.
2. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
3. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 11: 1133-1141.
4. Cua D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleu-kin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature All: 744-748.
5. Stumhofer, J. S. A. Laurence, E. H. Wilson, E. Huang, C. M. Tato, L. M. Johnson, A. V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7: 937-945.
6. + Th cells that cause autoimmune arthritis. J. Exp. Med. 204: 41-47.
7. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. J. Exp. Med. 203: 2673-2682.
8. Chan, J. R., W. Blumenschein, E. Murphy, C. Diveu, M. Wiekowski, S. Abbondanzo, L. Lucian, R. Geissler, S. Brodie and A. B. Kimball. 2006. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203: 2577-2587.
9. Zheng, Y., D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651.
10. Yen, D., J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. McKenzie, M. A. Kleinschek, A. Owyang, J. Mattson, W. Blumenschein, et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116: 1310-1316.
11. Fossiez, F., J. Banchereau, R. Murray, C. Van Kooten, P. Garrone, and S. Lebecque. 1998. Interleukin-17. Int. Rev. Immunol. 16: 541-551.
12. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
13. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
14. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinfiammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603.
15. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646.
16. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
17. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile, and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957.
18. Pène, J., M. Rahmoun, S. Temmerman, and H. Yssel. 2003. 0se of anti-CD3/CD28 mAb coupled magnetic beads permitting subsequent phenotypic analysis of activated human T cells by indirect immunofluorescence. J. Immunol. Methods 283: 59-66.
19. Yssel, H., J. E. De Vries, M. Koken, W. Van Blitterswijk, and H. Spits. 1984. A serum-free medium for the generation and propagation of functional human cy-totoxic and helper T cell clones. J. Immunol. Methods 72: 219-227.
20. + regulatory T cells obtained from cutaneous dinitrochlorobenzene- induced delayed type hypersensitivity reactions. J. Invest. Dermatol. 117: 318-325.
21. Moles, J. P., J. T. Schiller, A. Tesniere, I. M. Leigh, J. J. Guilhou, and N. Basset-Seguin. 1994. Analysis of HPV16 E6 and mutant p53-transfected ker-atinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J. Cell Sci. 107: 435-441.
22. Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3: RESEARCH0034. Epub 2002.
23. + T helper cells. Cell 126: 1121-1133.
24. Steinman, L. 2007. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
25. Kelso, A. 1995. Th1 and Th2 subsets: paradigms lost? Immunol. Today 16: 374-379.
26. Wolk, K., and R. Sabat. 2006. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17: 367-380.
27. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coex-pressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides J. Exp. Med. 203: 2271-2279.
28. Dumoutier, L. E. Van Roost, D. Colau, and J. C. Renauld. 2000. Human interleukin-10-reIated T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97: 10144-10149.
29. Boniface, K., F. X. Bernard, M. Garcia, A. L. Gurney, J. C. Lecron, and F. Morel. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174: 3695-3702.
30. Hör, S., H. Pirzer, L. Dumoutier, F. Bauer, S. Wittmann, H. Sticht, J.-C. Renauld, R. de Waal Malefyt, and H. Fickenscher. 2004. The T-cell lymphokine interleu-kin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleu-kin-10 receptor 2 chains. J. Biol. Chem. 279: 33343-33351.
31. 77 in the pathogenesis of psoriasis vulgaris. Lab. Invest. 81: 335-347.
32. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J. M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344-345.
33. Singh, S. P., H. H., Zhang. J. F., Foley, M. N. Hedrick, and J. M. Farber. 2008. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 180: 214-221.
34. Allen, S. J., S. E. Crown, and T. M. Handel. 2007. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25: 787-820.
35. Campbell, J., J. Hedrick, A. Zlotnik, M. Siani, D. Thompson, and E. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279: 381-384.
36. Homey, B., M. C. Dieu-Nosjean, A. Wiesenborn, C. Massacrier, J. J. Pin, E. Oldham, D. Catron, M. E. Buchanan, A. Müller, R. de Waal Malefyt, et al. 2000. Up-regulation of macrophage inflammatory protein-3 α/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164: 6621-6632.
37. Ikeuchi, H., T. Kuroiwa, N. Hiramatsu, Y. Kaneko, K. Hiromura, K. Ueki, and Y. Nojima. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52: 1037-1046.
38. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
39. Yang, D., O. Chcrtov, S. Bykovskaia, Q. Chen, M. Buffo, J. Shogan, M. Anderson, J. Schröder, J. Wang, O. Howard, and J. Oppcnheim. 1999. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
40. Kao, C. Y., F. Huang, Y. Chen, P. Thai, S. Wachi, C. Kim, L. Tarn, and R. Wu. 2005. IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κB signaling pathways. J. Immunol. 175: 6676-6685.
41. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8: 369-377.